Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 4 × Bone Diseases, Metabolic × Risedronic Acid × Clear all

Phase

Phase 4 2 Phase 3 2 Phase NA 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Osteoporosis 2 Breast Neoplasms 2 Bone Diseases, Metabolic 2 Prostatic Neoplasms 1

Interventions

Risedronic Acid 2 Kyphoplasty 1 Cholecalciferol 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00485953 2017-10-13

REBBeCA II

University of Pittsburgh

Phase 4 Completed

109 enrolled 11 charts

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00082277 2011-01-26

SABRE

AstraZeneca

Phase 4 Completed

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡